Howard Huang, MS

SVP, Business Development at CPC Scientific Inc.

Howard Huang is an accomplished professional with extensive experience in the pharmaceutical and biotech sectors. Currently serving as Senior Vice President and Head of Business Development and Sales at CPC Scientific Inc. since August 2012, Huang has played a significant role in the company’s growth, including its transition to a public entity following a $323 million acquisition in 2016. Huang also holds positions as Managing Director at Lake Capital, Leadership Team Member at the American Association of Pharmaceutical Scientists, and Advisor and Co-Chair at the Chinese American Biopharmaceutical Society. Previous roles include Regional Business Manager at GenScript Corporation and Executive Director at the Sino-American Pharmaceutical Professionals Association. Huang's educational background includes studies at Texas A&M University and Beijing University of Chemical Technology, complemented by a certificate in Strategic and Conceptual Selling from Miller Heiman.

Location

San Francisco, United States

Links


Org chart


Teams


Offices

This person is not in any offices


CPC Scientific Inc.

1 followers

With over 20 years of experience, CPC Scientific is a global CRDMO specializing in peptides and oligonucleotides. Our integrated service model supports partners through critical drug development stages, focusing on late-phase, large-scale, and commercial production. We provide GMP-grade synthetic peptides, oligonucleotides, and peptide-oligonucleotide conjugates, plus a wide range of custom and catalog research products. Our FDA- and ICH-compliant GMP facility ensures regulatory support for IND, NDA, and global filings. We offer process and method development, validation, stability studies, and regulatory documentation to accelerate your program from clinical trials to market. With scalable capacity from milligrams to 100 kilograms, flexible infrastructure, and a robust supply chain, CPC Scientific delivers dependable, high-quality results at every phase, providing the expertise and speed to bring your peptide and oligonucleotide programs to successful commercial production.


Employees

201-500

Links